山西省肿瘤医院2014-2016年中药注射剂使用合理性分析  

Rationality Analysis of Traditional Chinese Medicine Injection Used in Shanxi Tumor Hospital from 2014 to 2016

作　　者：卢宏丽[1] 卢宏霞[1] Lu Hongli;Lu Hongxia(Shanxi Tumor Hospital, Taiyuan 030013, China)

机构地区：[1]山西省肿瘤医院,太原030013

出　　处：《中国药事》2018年第5期675-681,共7页Chinese Pharmaceutical Affairs

摘　　要：目的:为临床合理使用中药注射剂提供参考。方法:收集山西省肿瘤医院2014-2016年中药注射剂品种、销售金额等数据,采用限定日剂量(DDD)法和ABC分类法对中药注射剂的使用合理性进行分析。结果:2014-2016年我院中药注射剂的DDDs呈逐年增加的趋势,分别为421572.1、494534.1、537426.2,DDC基本保持稳定,大多数品种的用药同步性较好。ABC分类结果显示临床应用结构存在不合理现象。我院被临床较好认可的品种为复方苦参注射液、康艾注射液、血必净注射液。结论:我院中药注射剂使用稳定,但存在临床应用结构不合理现象,应重视A类药品的用药合理性。Objective： To provide references for rational clinical use of traditional Chinese medicine injection（TCMI）. Methods： The varieties, sale amount and other data of the TCMI in Shanxi Tumor Hospital from 2014 to 2016 were collected. The rationality of the TCMI was analyzed by ABC classification method and defined daily dose（DDD） method. Results： DDDs of TCMI in the hospital gradually increased from 2014 to 2016, that is, 421572.1 in 2014, 494534.1 in 2015, and 537426.2 in 2016. DDC basically remained stable and most of the varieties had good synchronization. The ABC classification result showed that the clinical application structure was unreasonable. The preferred varieties consisted of compound matrine injection, Kang＇ai injection and Xuebijing injection. Conclusion： The use of TCMI in the hospital was stable, while the clinical application structure was unreasonable. The rationality of Class A drug should be paid attention to.

关 键 词：中药注射剂 限定日剂量 ABC分类法 合理性 

分 类 号：R286[医药卫生—中药学] R283[医药卫生—中医学]